Raptin, a novel brain hormone links sleep health to body weight gain
Leonie Cabot,
No information about this author
Henning Fenselau
No information about this author
Cell Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 17, 2025
Language: Английский
Caveolin-1 negatively regulates the calcitonin receptor-like receptor and neuroinflammation in a female mouse model of migraine
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: May 21, 2025
Caveolin-1
(CAV1),
a
scaffolding
protein
critical
for
caveolae
formation,
regulates
G-protein-coupled
receptor
(GPCR)
signaling
via
caveolae-mediated
endocytosis.
The
calcitonin
receptor-like
(CLR),
GPCR
and
core
subunit
of
the
gene-related
peptide
(CGRP)
receptor,
is
therapeutic
target
migraine.
However,
role
CAV1
in
CLR
regulation
migraine
remains
unclear.
A
model
was
established
female
mice
dural
inflammatory
soup
(IS)
application.
Migraine-like
behaviors
were
assessed
using
Von
Frey
filament,
spontaneous
pain
behavior
counts,
light/dark
box,
acetone
test.
overexpressed
by
lentivirus
downregulated
small
interfering
RNA
(siRNA)
technology.
Methyl-β-cyclodextrin
(MβCD)
used
to
inhibit
molecular
mechanism
on
neuroinflammation
investigated
biochemistry,
multiplex
immunohistochemistry
staining,
internalization
assay,
co-immunoprecipitation.
Repeated
IS
stimulation
elevated
expression
trigeminal
nucleus
caudalis
(TNC),
concurrently
activating
ERK/CREB
signaling,
promoting
microglial
activation,
increasing
cytokines
(TNFα,
IL-1β).
directly
interacted
with
CLR,
its
degradation.
knockdown
TNC
exacerbated
pathology,
characterized
accumulation,
enhanced
phosphorylation,
amplified
neuroinflammation.
Conversely,
overexpression
or
MβCD-mediated
disruption
normalized
levels,
reduced
hyperactivity,
reversed
nociceptive
behaviors.
negatively
stability,
suppressing
inflammation
preclinical
model.
These
findings
suggest
that
contributes
migraine-related
hyperalgesia
may
represent
novel
treatment.
Language: Английский
Obesity and the accelerated decline in total sleep time increases the self-reported diagnoses of diabetes
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 12, 2025
The
aim
of
this
study
was
to
investigate
the
relationship
between
obesity
and
accelerated
decline
in
Total
Sleep
Time
(TST)
its
potential
impact
on
self-reported
diagnoses
diabetes.
Our
addresses
gap
by
analyzing
trends
a
longitudinal
cohort
conducted
China,
using
data
from
China
Health
Nutrition
Survey
(CHNS).
Employing
joint
model,
inter-individual
variability
intra-individual
TST,
diabetes
were
considered.
findings
reveal
that
prevalence
rose
1.10%
2004
3.06%
2015,
accompanied
decrease
average
TST
8.12
7.80.
With
age,
decreased
0.01
per
year.
Among
coffee
or
tea
consumers,
it
0.03,
while
alcohol
users
saw
0.07.
obese
group
experienced
0.05,
overweight
normal
weight
0.01.
Each
1-hour
associated
with
substantial
3.61-fold
increase
risk
(95%
CI:
2.92-4.44).
Specifically,
individuals
higher
baseline
tend
experience
smaller
changes
over
time,
whereas
those
lower
larger
changes.
For
obese,
decreases
at
an
rate
which
contributes
underscore
role
sleep
loss
risk,
implications
for
public
policy.
Future
research
interventions
should
emphasise
management,
particularly
metabolic
health,
develop
more
effective
prevention
treatment
strategies.
Language: Английский